2010
DOI: 10.1002/ejoc.201000549
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Pyridodiazepinediones by Using the Ugi Multicomponent Reaction

Abstract: Benzodiazepines show a broad spectrum of biological activities. In an ongoing effort to extend molecular diversity in this type of systems, we developed a strategy for synthesizing3,4‐dihydro‐1H‐pyrido[2,3‐e][1,4]diazepine‐2,5‐dione compounds starting from 2‐hydroxynicotinic acid and by using an Ugi reaction as a key step in the synthesis. We opted to use 2‐isocyanophenyl benzoate instead of Armstrong's convertible isocyanide in this multicomponent reaction.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
3
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 20 publications
(4 citation statements)
references
References 23 publications
(6 reference statements)
1
3
0
Order By: Relevance
“…In contrast to the C3-benzyl and C3-alkyl derivatives 3d , 3e , 3j – 3l , the NMR spectra of the C3-phenyl-substituted products 3a – 3c and 3f – 3i indicated a single set of resonances. The conformational behavior is consistent with that observed in related 1,4-benzodiazepine-2,5-diones. ,, …”
supporting
confidence: 85%
“…In contrast to the C3-benzyl and C3-alkyl derivatives 3d , 3e , 3j – 3l , the NMR spectra of the C3-phenyl-substituted products 3a – 3c and 3f – 3i indicated a single set of resonances. The conformational behavior is consistent with that observed in related 1,4-benzodiazepine-2,5-diones. ,, …”
supporting
confidence: 85%
“…1). Commercially available 2-hydroxynicotinic acid 1 was converted to dihalonicotinic acid 3 via two sequential halogenation reactions (Van den Bogaert et al, 2010;Gero et al, 1989;Haché et al, 2002), after which a benzylamine substituent was introduced yielding the aza-anthranilic acid derivative 4. Next, ester compound 5 was prepared from intermediate 4 and tert-butyl glycinate using a standard coupling procedure.…”
Section: Chemical Contextmentioning
confidence: 99%
“…Among the variety of heterocyclic acids used in Ugi-4CR [1519 2142] only a few of them in addition to bearing a simple pharmacophore core (group I, Scheme 1) are also characterized by the complexity and diversity of the skeleton itself gained through multi-step transformations (group II) [1819 3436] or allow for generating additional diversity through post-cyclization reactions (group III) [18,3542]. Meanwhile the complexity of the acid skeleton can be achieved by MCR.…”
Section: Introductionmentioning
confidence: 99%